Acute myeloid leukemia (AML) poses an increasing global burden for older adults, according to a study published online Aug.

The exact cause of acute myeloid leukemia (AML) is unclear, but risk factors can include older age, radiation exposure, smoking, certain genetic conditions, and more. Acute myeloid leukemia (AML) is a ...

In 2001, imatinib was the first proof that small molecule inhibitors targeting molecular drivers of cancer could be an ...

A new study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months. A ...

Patients who maintained venetoclax concentrations above 2605 ng/mL were more likely to stay in remission, while those exceeding 4060 ng/mL faced a higher risk of toxicity.

A highly sensitive bone marrow test could double survival rates for some groups of younger adults with acute myeloid leukemia (AML) by helping doctors identify if they might relapse up to three months ...

Journalist and author Tatiana Schlossberg, President John F. Kennedy's granddaughter, Caroline Kennedy's daughter and Jack Sch l ossberg's sister, revealed earlier this month she has been diagnosed ...

<?xml encoding="utf-8" ?> Enliven Therapeutics Inc. ELVN drew an Outperform rating from William Blair on Tuesday as the firm initiated coverage, citing the potential for lead drug candidate ELVN-001 ...

SELLAS Life Sciences (SLS) stock soars 255% YTD as Phase 3 AML trial hits critical milestone. Analysts set $10 target amid ...